VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS20003375 | HPV | ENSG00000204681.11 | protein_coding | GABBR1 | No | No | 2550 | Q5SUJ9 Q8IW08 Q9UBS5 |
TVIS20006860 | HPV | ENSG00000204681.11 | protein_coding | GABBR1 | No | No | 2550 | Q5SUJ9 Q8IW08 Q9UBS5 |
TVIS44022560 | HTLV-1 | ENSG00000204681.11 | protein_coding | GABBR1 | No | No | 2550 | Q5SUJ9 Q8IW08 Q9UBS5 |
TVIS44022561 | HTLV-1 | ENSG00000204681.11 | protein_coding | GABBR1 | No | No | 2550 | Q5SUJ9 Q8IW08 Q9UBS5 |
TVIS44050516 | HTLV-1 | ENSG00000204681.11 | protein_coding | GABBR1 | No | No | 2550 | Q5SUJ9 Q8IW08 Q9UBS5 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | GABBR1 |
---|---|
DrugBank ID | DB01956 |
Drug Name | Taurine |
Target ID | BE0000217 |
UniProt ID | Q9UBS5 |
Regulation Type | agonist |
PubMed IDs | 29123472 |
Citations | Kilb W, Fukuda A: Taurine as an Essential Neuromodulator during Perinatal Cortical Development. Front Cell Neurosci. 2017 Oct 24;11:328. doi: 10.3389/fncel.2017.00328. eCollection 2017. |
Groups | Approved; Nutraceutical |
Direct Classification | Organosulfonic acids |
SMILES | NCCS(O)(=O)=O |
Pathways | Congenital Bile Acid Synthesis Defect Type II; Familial Hypercholanemia (FHCA); Bile Acid Biosynthesis; Zellweger Syndrome; Congenital Bile Acid Synthesis Defect Type III; Taurine and Hypotaurine Metabolism; 27-Hydroxylase Deficiency; Cerebrotendinous Xanthomatosis (CTX) |
PharmGKB | PA451590 |
ChEMBL | CHEMBL239243 |